Dublin, April 20, 2026 (GLOBE NEWSWIRE) — The “Softgel Capsules Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030” has been added to ResearchAndMarkets.com’s offering.
The Global Softgel Capsules Market, valued at USD 8.02 Billion in 2024, is projected to experience a CAGR of 7.86% to reach USD 12.63 Billion by 2030
The market’s growth is primarily driven by several distinct factors, including the inherent benefits of softgel formulations such as improved bioavailability and ease of swallowing, increased demand for dietary supplements and nutraceuticals, and the rising prevalence of chronic diseases necessitating effective drug delivery. These attributes facilitate enhanced patient compliance and expand application across pharmaceutical, nutraceutical, and cosmetic sectors.
Key Market Drivers
The global softgel capsules market expansion is significantly propelled by the growing demand for dietary supplements and nutraceuticals, alongside rising consumer health awareness and a proactive approach to preventive healthcare. The burgeoning nutraceutical sector, which frequently utilizes softgel formulations for their effective delivery of active ingredients, remains a primary catalyst.
According to the IADSA, at the start of 2023, the worldwide market for supplements was larger than USD 170 billion, underscoring the substantial base driving softgel production in this segment. This robust demand is further amplified by a global shift towards preventative health measures and increased consumer understanding of nutrition’s role in well-being. This trend encourages a consistent uptake of supplements, for which softgels offer an appealing and convenient dosage form.
Key Market Challenges
A significant challenge impeding the expansion of the global softgel capsules market is the high production costs associated with specialized encapsulation machinery, stringent manufacturing controls, and the rising prices of raw materials.
These economic factors directly influence the operational profitability and growth strategies of manufacturers within the sector. The substantial investment required for advanced encapsulation technologies, alongside the ongoing expenses of maintaining rigorous quality and regulatory compliance, significantly elevates overall manufacturing overheads.
Key Market Trends
The growing consumer preference for vegan and vegetarian products, coupled with increasing health and ethical considerations, is significantly driving the adoption of plant-based encapsulation materials in the softgel capsules market. This trend involves a shift from traditional animal-derived gelatin to alternatives such as pullulan, starch, and hydroxypropyl methylcellulose, which cater to a broader demographic seeking ethical and sustainable options.
The move towards plant-based ingredients is evident in manufacturing capacity, with the Pharmaceutical Research and Manufacturers of America (PhRMA) reporting that Catalent alone accounted for nearly 14% of global plant-based capsule manufacturing capacity in 2023. This expansion underscores the market’s response to evolving dietary preferences and clean label demands. In a notable development, IFF introduced new pectin-based technology in April 2023 to expand its vegan softgel offerings, reflecting industry innovation in sustainable solutions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $8.02 Billion |
| Forecasted Market Value (USD) by 2030 | $12.63 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
Report Scope
Key Market Players Profiled:
- Fuji Capsule Co Ltd
- Sirio Pharma Co Ltd
- Captek Softgel International Inc
- Thermo Fisher Scientific Inc
- EyePoint Pharmaceuticals Inc
- Catalent Inc
- EuroCaps Ltd
- Aenova Group GmbH
- Lonza Group AG
- Soft Gel Technologies Inc.
By Type:
- Gelatin-Based/Animal-Based
- Non-Animal-Based
By Application:
- Antacid and Anti-Flatulent Preparation
- Anti-Anemic Preparations
- Anti-Inflammatory Drugs
- Antibiotic and Antibacterial Drugs
- Cough and Cold Preparations
- Health Supplement
- Vitamin and Dietary Supplement
- Pregnancy
- Others
By End Use:
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organization
By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/fw5vz3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
